Cerebrolysin vs Selank
Side-by-side comparison of Cerebrolysin, Selank — mechanism, dosing, half-life, side effects, and research status.
| Attribute | Cerebrolysin Cerebrolysin (Porcine Brain-Derived Neuropeptide Mixture) Cognitive | Selank Selank (Tuftsin Analogue Heptapeptide) Cognitive |
|---|---|---|
| Basics | ||
| Molecular type | Neuropeptide Mixture | Anxiolytic Neuropeptide |
| Amino acids | — | 7 |
| Molecular weight | — | 751.9 Da |
| Half-life | Short (hours) | ~minutes (nasal); prolonged CNS effect |
| Route(s) | Intravenous (IV), Intramuscular | Intranasal, Subcutaneous |
| Mechanism & Research | ||
| Primary mechanism | Cerebrolysin's mechanism is attributed to its low-molecular-weight peptide fraction, which crosses the blood-brain barrier and exerts BDNF-like, NGF-like, and VEGF-like neurotrophic effects. It stimulates neuroplasticity… | Selank modulates GABA-A receptor function via an allosteric mechanism distinct from benzodiazepines, producing anxiolytic effects without sedation or tolerance development. It also enhances GABA receptor sensitivity with… |
| Research status | Research Compound | Research Compound |
| Evidence summary | Cerebrolysin has one of the most extensive clinical research programmes of any nootropic compound, with over 100 controlled trials across Alzheimer's disease, stroke, TBI, and vascular dementia. Evidence is mixed across … | Selank is approved in Russia for anxiety disorders and cognitive enhancement. Clinical studies demonstrate anxiolytic efficacy without dependence in generalised anxiety disorder. Western research is emerging. |
| Protocol & Dosing | ||
| Typical dose | 10–30 mL per session (IV); 5–10 mL IM | 250–500 mcg/day (intranasal) |
| Frequency | Daily for 10–20 day courses | 1–2x daily |
| Duration | 10–20 day IV course, repeated quarterly | 2–4 weeks |
| Timing | Morning | Morning and/or before stressful activities |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Not Prohibited | Not Prohibited |
| Deeper reading | ||
| Related peptides | Semax, Dihexa, Selank | Semax, P21, DSIP |
| Full profile | Read full Cerebrolysin profile → | Read full Selank profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.